0001654954-18-000284.txt : 20180222 0001654954-18-000284.hdr.sgml : 20180222 20180110160208 ACCESSION NUMBER: 0001654954-18-000284 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MusclePharm Corp CENTRAL INDEX KEY: 0001415684 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770664193 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 BUSINESS PHONE: (800) 210-7369 MAIL ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 FORMER COMPANY: FORMER CONFORMED NAME: Tone in Twenty DATE OF NAME CHANGE: 20071018 CORRESP 1 filename1.htm Blueprint
Musclepharm Corporation
4400 Vanowen Street
Burbank, CA 91505
(303) 396-6100
 
January 10, 2018
 
BY EDGAR
 
Securities and Exchange CommissionOffice of Global Security Risk
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Cecilia Blye
 
 
Re:    
Comment Letter Dated December 22, 2017
 
Musclepharm Corporation
            
Form 10-K for Fiscal Year Ended December 31, 2016
 
File No. 0-53166
 
Dear Ms. Blye:
 
Musclepharm Corporation (the “Company”) hereby submits a request for an extension to respond to the comment letter referenced above until January 22, 2018. Due to reduced resources available at the Company during the recent holiday break, the Company will require additional time to prepare its response.
 
If you have any questions relating to the foregoing, please contact the undersigned at (818) 658-3806.
 
 
Sincerely,
 
Musclepharm Corporation
 
By: /s/ Kevin Harris                             
Name: Kevin Harris
Title: Interim Chief Financial Officer